The Clorox Company (NYSE:CLX) Shares Sold by UMB Bank n.a.
UMB Bank n.a. trimmed its holdings in shares of The Clorox Company (NYSE:CLX – Get Rating) by 11.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,347 shares of the company’s stock after selling 1,654 shares during the period. UMB Bank n.a.’s holdings in Clorox were worth $1,732,000 at the end of the most recent quarter.
→ My No. 1 dividend stock for a LIFETIME of income. (From Oxford Club)
Several other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Clorox by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 14,685,046 shares of the company’s stock valued at $2,041,661,000 after purchasing an additional 185,012 shares during the period. BlackRock Inc. lifted its stake in shares of Clorox by 5.6% in the 3rd quarter. BlackRock Inc. now owns 10,964,049 shares of the company’s stock valued at $1,407,673,000 after purchasing an additional 580,982 shares during the period. State Street Corp lifted its stake in shares of Clorox by 9.6% in the 2nd quarter. State Street Corp now owns 8,907,083 shares of the company’s stock valued at $1,255,721,000 after purchasing an additional 778,269 shares during the period. Wells Fargo & Company MN lifted its stake in shares of Clorox by 2.4% in the 2nd quarter. Wells Fargo & Company MN now owns 3,557,161 shares of the company’s stock valued at $501,489,000 after purchasing an additional 82,698 shares during the period. Finally, Federated Hermes Inc. lifted its stake in shares of Clorox by 11.1% in the 3rd quarter. Federated Hermes Inc. now owns 2,161,323 shares of the company’s stock valued at $277,492,000 after purchasing an additional 215,425 shares during the period. 79.12% of the stock is currently owned by institutional investors and hedge funds.
Clorox Price Performance
Clorox stock opened at $153.99 on Friday. The company has a quick ratio of 0.47, a current ratio of 0.86 and a debt-to-equity ratio of 5.04. The Clorox Company has a 52-week low of $120.50 and a 52-week high of $160.59. The company has a fifty day simple moving average of $149.25 and a 200-day simple moving average of $144.53. The firm has a market capitalization of $19.02 billion, a price-to-earnings ratio of 44.00, a PEG ratio of 3.16 and a beta of 0.29.
Clorox (NYSE:CLX – Get Rating) last announced its quarterly earnings data on Thursday, February 2nd. The company reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.66 by $0.32. Clorox had a net margin of 6.16% and a return on equity of 89.97%. The firm had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.66 billion. During the same quarter in the prior year, the firm posted $0.66 earnings per share. Clorox’s quarterly revenue was up 1.4% on a year-over-year basis. On average, equities analysts anticipate that The Clorox Company will post 4.23 EPS for the current fiscal year.
Clorox Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 12th. Investors of record on Wednesday, April 26th will be issued a $1.18 dividend. This represents a $4.72 dividend on an annualized basis and a dividend yield of 3.07%. The ex-dividend date of this dividend is Tuesday, April 25th. Clorox’s dividend payout ratio is currently 134.86%.
Analyst Upgrades and Downgrades
CLX has been the subject of several analyst reports. Barclays decreased their target price on shares of Clorox from $110.00 to $108.00 and set an “underweight” rating for the company in a research note on Monday, February 6th. UBS Group upped their price objective on shares of Clorox from $129.00 to $140.00 in a research report on Friday, February 3rd. StockNews.com started coverage on shares of Clorox in a research report on Thursday. They set a “hold” rating for the company. Wells Fargo & Company upped their price objective on shares of Clorox from $125.00 to $135.00 and gave the stock an “underweight” rating in a research report on Tuesday, January 3rd. Finally, JPMorgan Chase & Co. upped their price objective on shares of Clorox from $126.00 to $135.00 and gave the stock an “underweight” rating in a research report on Friday, January 13th. Seven equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $141.33.
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to email@example.com.
Before you consider Clorox, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Clorox wasn’t on the list.
While Clorox currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.